StockData
BioStem Technologies, Inc. logo

BioStem Technologies, Inc. (BSEM) company profile

BSEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$0.64−0.07 (-10.23%)

Close on Nov 20, 2026Market cap $11.34MP/E –Yield –

About BioStem Technologies

Biological Products, (No Diagnostic Substances), SIC 2836

BioStem Technologies, Inc. is listed on Nasdaq under the ticker BSEM, in the SEC industry Biological Products, (No Diagnostic Substances). It is incorporated in Florida and its fiscal year ends on December 31. Reported financials on StockData start in fiscal 2024.

Company profile

Company

Legal name
BioStem Technologies, Inc.
Headquarters
Pompano Beach, FL
Address
2836 Center Port Circle 33604
Phone
(954) 380-8342
Industry
Biological Products, (No Diagnostic Substances)
Incorporated in
Florida
Fiscal year ends
December 31

Stock & identifiers

Ticker
BSEM
Exchange
Nasdaq
IPO date
Mar 17, 2015
Shares outstanding
18M, Aug 12, 2026
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SEC CIK
1658678
CUSIP
090684200
ISIN
US0906842002
FIGI
BBG000JZMH09
Share class FIGI
BBG001SC0G68
LEI
54930046GKCRPVZDQH50
EIN
27-0400416

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Jason MatuszewskiChief Executive Officer, Director1,539,251
Vurst Andrew Smith-VanChief Operating Officer, Director1,789,809
Brandon PoeChief Financial Officer60,763
Michael A. FortunatoChief Accounting Officer69,634
Barry HassettChief Commercial Officer5,256
Katherine GorrellCLCO–
Kenneth Howard Warrington JrDirector33,928
Mark A. GlickmanDirector7,671
Hannaway Rayna LesserDirector7,671
Jodi UngrodtDirector11,295
Steven D. SonenreichDirector7,671

Corporate history

Events identified from SEC filings

DateEventDetails
Oct 28, 2025Name changeName changed from BIOSTEM TECHNOLOGIES to BioStem Technologies, Inc.
Sep 27, 2024Spin-offRegistration as a new public company (Form 10), e.g. spin-off

See a number that looks wrong?